Your shopping cart is currently empty

Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $540 | In Stock | In Stock | |
| 5 mg | $1,260 | In Stock | In Stock | |
| 10 mg | $1,630 | In Stock | In Stock | |
| 25 mg | $2,460 | In Stock | In Stock | |
| 50 mg | $3,290 | In Stock | In Stock | |
| 100 mg | $4,470 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $1,190 | In Stock | In Stock |

| Description | Melagatran is an orally available, direct synthetic thrombin inhibitor that does not require endogenous cofactors other than thrombin and does not significantly interact with any other enzymes in the coagulation cascade or with the fibrinolytic enzymes. |
| In vivo | METHODS: To test the hypothesis that a regimen consisting of an oral thrombin inhibitor would delay or prevent occlusive clot formation, anesthetized dogs were given melagatran (1.5, 2.5 mg/kg) via nasogastric tube, and 15 minutes later, a potent thrombogenic stimulus in the form of an anodic current (100 μA) was applied to the intimal surface of the stenotic left anterior descending coronary artery (LAD). RESULTS One of the dogs given high-dose melagatran did not develop thrombotic occlusion of the LAD during the entire 4-hour observation period. In the melagatran-treated dogs, coronary artery occlusions occurred during the observation period in 68% (low-dose) and 75% (high-dose) of the dogs.[2] |
| Molecular Weight | 429.51 |
| Formula | C22H31N5O4 |
| Cas No. | 159776-70-2 |
| Smiles | C([C@H](NCC(O)=O)C1CCCCC1)(=O)N2[C@H](C(NCC3=CC=C(C(=N)N)C=C3)=O)CC2 |
| Relative Density. | 1.41 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (104.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.